📖

Claustrum-in-Alzheimers-Disease

wiki page Created: 2026-04-02 13:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-cell-types-claustrum-in-alzheimers-

Related Entities

cell-types-claustrum-in-alzheimers-disease

Metadata

slug	cell-types-claustrum-in-alzheimers-disease
entity_type	cell_type
kg_node_id	None

Linked Artifacts (246)

related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De70%

related🧪Temporal Decoupling via Circadian Clock Reset55%

related🧪TREM2 Conformational Stabilizers for Synaptic Discrimination55%

related🧪Netrin-1 Gradient Restoration55%

related🧪Oligodendrocyte White Matter Vulnerability55%

related🧪Smartphone-Detected Motor Variability Correction55%

related🧪Purinergic Signaling Polarization Control55%

related🧪Brain Insulin Resistance with Glucose Transporter Dysfunctio55%

related🧪Mitochondrial-Lysosomal Contact Site Engineering55%

related🧪Osmotic Gradient Restoration via Selective AQP1 Enhancement 55%

related🧪Circadian-Synchronized Proteostasis Enhancement55%

related🧪Mitochondrial-Nuclear Epigenetic Cross-Talk Restoration55%

related🧪Selective HDAC3 Inhibition with Cognitive Enhancement55%

related🧪HSP90-Tau Disaggregation Complex Enhancement55%

related🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer55%

related🧪Ganglioside Rebalancing Therapy55%

related🧪Mitochondrial SPM Synthesis Platform Engineering55%

related🧪CX43 hemichannel engineering enables size-selective mitochon55%

related🧪APOE Isoform Conversion Therapy55%

related🧪Astrocytic Connexin-43 Upregulation Enhances Neuroprotective55%

related🧪APOE-TREM2 Interaction Modulation55%

related🧪VCP-Mediated Autophagy Enhancement55%

related🧪Arginine Methylation Enhancement Therapy55%

related🧪Senescent Cell Mitochondrial DNA Release55%

related🧪SASP-Mediated Cholinergic Synapse Disruption55%

related🧪Mitochondrial RNA Granule Rescue Pathway55%

related🧪Multi-Modal Stress Response Harmonization55%

related🧪Complement C1q Mimetic Decoy Therapy55%

related🧪Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modu55%

related🧪Restoring Neuroprotective Tryptophan Metabolism via Targeted55%

related🧪RAB27A-dependent extracellular vesicle engineering for mitoc55%

related🧪CYP46A1 Overexpression Gene Therapy55%

related🧪Liquid-Liquid Phase Separation Modifier Therapy55%

related🧪Epigenetic Memory Reprogramming for Alzheimer's Disease55%

related🧪PINK1/Parkin-Independent Mitophagy Bypass for Enhanced Donor55%

related🧪Enteric Nervous System Prion-Like Propagation Blockade55%

related🧪Age-Dependent Complement C4b Upregulation Drives Synaptic Vu55%

related🧪TREM2-Mediated Selective Aggregate Clearance Pathway55%

related🧪Designer TRAK1-KIF5 fusion proteins accelerate therapeutic m55%

related🧪Retinal Vascular Microcirculation Rescue55%

related🧪Metabolic Reprogramming via Microglial Glycolysis Inhibition55%

related🧪Trinucleotide Repeat Sequestration via CRISPR-Guided RNA Tar55%

related🧪Astroglial Gap Junction Coordination via Connexin-43 Phospho55%

related🧪Targeted Butyrate Supplementation for Microglial Phenotype M55%

related🧪Metabolic Circuit Breaker via Lipid Droplet Modulation55%

related🧪Senescent Microglia Resolution via Maresins-Senolytics Combi55%

related🧪Noradrenergic-Tau Propagation Blockade55%

related🧪Adenosine-Astrocyte Metabolic Reset55%

related🧪AMPK hypersensitivity in astrocytes creates enhanced mitocho55%

related🧪APOE4 Allosteric Rescue via Small Molecule Chaperones55%

related🧪Palmitoylation-Targeted BACE1 Trafficking Disruptors55%

related🧪Microglial Efferocytosis Enhancement via GPR32 Superagonists55%

related🧪Synthetic Biology Approach: Designer Mitochondrial Export Sy55%

related🧪Biorhythmic Interference via Controlled Sleep Oscillations55%

related🧪Quantum Coherence Disruption in Cellular Communication55%

related🧪The Glial Ketone Metabolic Shunt Hypothesis55%

related🧪Nutrient-Sensing Epigenetic Circuit Reactivation55%

related🧪LRP1-Dependent Tau Uptake Disruption55%

related🧪Cryptic Exon Silencing Restoration55%

related🧪SIRT6-NAD+ Axis Enhancement Therapy55%

related🧪Synaptic Phosphatidylserine Masking via Annexin A1 Mimetics55%

related🧪APOE-Dependent Autophagy Restoration55%

related🧪Glycosaminoglycan Template Disruption Approach55%

related🧪Extracellular Vesicle Biogenesis Modulation55%

related🧪Circadian Rhythm Entrainment of Reactive Astrocytes55%

related🧪Grid Cell-Specific Metabolic Reprogramming via IDH2 Enhancem55%

related🧪SASP-Mediated Complement Cascade Amplification55%

related🧪APOE-Mediated Synaptic Lipid Raft Stabilization55%

related🧪Complement C1q Subtype Switching55%

related🧪Proteostasis Enhancement via APOE Chaperone Targeting55%

related🧪Microglial Purinergic Reprogramming55%

related🧪Heat Shock Protein 70 Disaggregase Amplification55%

related🧪Autophagosome Maturation Checkpoint Control55%

related🧪Astrocytic Lactate Shuttle Enhancement for Grid Cell Bioener55%

related🧪TREM2-Dependent Microglial Senescence Transition55%

related🧪Glymphatic System-Enhanced Antibody Clearance Reversal55%

related🧪Prefrontal sensory gating circuit restoration via PV interne55%

related🧪Chaperone-Mediated APOE4 Refolding Enhancement55%

related🧪Context-Dependent CRISPR Activation in Specific Neuronal Sub55%

related🧪Sphingolipid Metabolism Reprogramming55%

related🧪PARP1 Inhibition Therapy55%

related🧪Low Complexity Domain Cross-Linking Inhibition55%

related🧪Ocular Immune Privilege Extension55%

related🧪Hypocretin-Neurogenesis Coupling Therapy55%

related🧪Gut Barrier Permeability-α-Synuclein Axis Modulation55%

related🧪GAP43-mediated tunneling nanotube stabilization enhances neu55%

related🧪Extracellular Matrix Stiffness Modulation55%

related🧪Synaptic Vesicle Tau Capture Inhibition55%

related🧪Pericyte Contractility Reset via Selective PDGFR-β Agonism55%

related🧪Microbial Metabolite-Mediated α-Synuclein Disaggregation55%

related🧪Perforant Path Presynaptic Terminal Protection Strategy55%

related🧪RNA-Binding Competition Therapy for TDP-43 Cross-Seeding55%

related🧪Optogenetic Microglial Deactivation via Engineered Inhibitor55%

related🧪DNMT1-Targeting Antisense Oligonucleotide Reset55%

related🧪Senescence-Induced Lipid Peroxidation Spreading55%

related🧪Piezoelectric Nanochannel BBB Disruption55%

related🧪Bacterial Enzyme-Mediated Dopamine Precursor Synthesis55%

related🧪Lipid Droplet Dynamics as Phenotype Switches55%

related🧪Circadian-Synchronized LRP1 Pathway Activation55%

related🧪Glycine-Rich Domain Competitive Inhibition55%

related🧪SASP-Driven Aquaporin-4 Dysregulation55%

related🧪Axonal RNA Transport Reconstitution55%

related🧪Optogenetic Control of Mitochondrial Transfer Networks55%

related🧪Metabolic Reprogramming via Coordinated Multi-Gene CRISPR Ci55%

related🧪Matrix Stiffness Normalization via Targeted Lysyl Oxidase In55%

related🧪Circadian-Gated Maresin Biosynthesis Amplification55%

related🧪Synthetic Biology BBB Endothelial Cell Reprogramming55%

related🧪Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna55%

related🧪Orexin-Microglia Modulation Therapy55%

related🧪KDM6A-Mediated H3K27me3 Rejuvenation55%

related🧪Lysosomal Membrane Repair Enhancement55%

related🧪Targeting Bacterial Curli Fibrils to Prevent α-Synuclein Cro55%

related🧪Prohibitin-2 Mitochondrial Cross-Seeding Hub Disruption55%

related🧪Sleep Spindle-Synaptic Plasticity Enhancement55%

related🧪Lysosomal Calcium Channel Modulation Therapy55%

related🧪Blocking AGE-RAGE Signaling in Enteric Glia to Prevent Neuro55%

related🧪Astrocyte-Mediated Neuronal Epigenetic Rescue55%

related🧪Miro1-Mediated Mitochondrial Trafficking Enhancement Therapy55%

related🧪Blood-Brain Barrier SPM Shuttle System55%

related🧪Mitochondrial Transfer Pathway Enhancement55%

related🧪Stress Granule Phase Separation Modulators55%

related🧪TFAM overexpression creates mitochondrial donor-recipient gr55%

related🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction55%

related🧪Pharmacological Enhancement of APOE4 Glycosylation55%

related🧪Gap Junction Hemichannel Modulation for Controlled Mitochond55%

related🧪Programmable Neuronal Circuit Repair via Epigenetic CRISPR55%

related🧪Membrane Cholesterol Gradient Modulators55%

related🧪Circadian Glymphatic Entrainment via Targeted Orexin Recepto55%

related🧪Aquaporin-4 Polarization Enhancement via TREK-1 Channel Modu55%

related🧪Flotillin-1 Stabilization Compounds55%

related🧪Metabolic Switch Targeting for A1→A2 Repolarization55%

related🧪Targeted APOE4-to-APOE3 Base Editing Therapy55%

related🧪Enhancing Vagal Cholinergic Signaling to Restore Gut-Brain A55%

related🧪Complement-Mediated Synaptic Pruning Dysregulation55%

related🧪Cholesterol-CRISPR Convergence Therapy for Neurodegeneration55%

related🧪Temporal TET2-Mediated Hydroxymethylation Cycling55%

related🧪HDAC3-Selective Inhibition for Clock Reset55%

related🧪Magnetosonic-Triggered Transferrin Receptor Clustering55%

related🧪Mitochondrial Calcium Buffering Enhancement via MCU Modulati55%

related🧪Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th55%

related🧪Chromatin Accessibility Restoration via BRD4 Modulation55%

related🧪Transcriptional Autophagy-Lysosome Coupling55%

related🧪Digital Twin-Guided Metabolic Reprogramming55%

related🧪TREM2-mediated microglial tau clearance enhancement55%

related🧪Lysosomal Positioning Dynamics Modulation55%

related🧪Lysosomal Enzyme Trafficking Correction55%

related🧪Circadian Clock-Autophagy Synchronization55%

related🧪Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides55%

related🧪Fractalkine Axis Amplification via CX3CR1 Positive Allosteri55%

related🧪Partial Neuronal Reprogramming via Modified Yamanaka Cocktai55%

related🧪Senescence-Associated Myelin Lipid Remodeling55%

related🧪Gamma entrainment therapy to restore hippocampal-cortical sy55%

related🧪Glial Glycocalyx Remodeling Therapy55%

related🧪R-Loop Resolution Enhancement Therapy55%

related🧪Aquaporin-4 Polarization Rescue55%

related🧪HSP70 Co-chaperone DNAJB6 Universal Cross-Seeding Inhibitor55%

related🧪APOE4-Selective Lipid Nanoemulsion Therapy55%

related🧪Senescence-Activated NAD+ Depletion Rescue55%

related🧪Competitive APOE4 Domain Stabilization Peptides55%

related🧪Epigenetic Memory Erasure via TET2 Activation55%

related🧪Reelin-Mediated Cytoskeletal Stabilization Protocol55%

related🧪Correcting Gut Microbial Dopamine Imbalance to Support Syste55%

related🧪HCN1-Mediated Resonance Frequency Stabilization Therapy55%

related🧪Transglutaminase-2 Cross-Linking Inhibition Strategy55%

related🧪TET2-Mediated Demethylation Rejuvenation Therapy55%

related🧪Microglia-Derived Extracellular Vesicle Engineering for Targ55%

related🧪Mechanosensitive Ion Channel Reprogramming55%

related🧪Serine/Arginine-Rich Protein Kinase Modulation55%

related🧪Selective Acid Sphingomyelinase Modulation Therapy55%

related🧪Circadian Glymphatic Rescue Therapy (Melatonin-focused)55%

related🧪Vocal Cord Neuroplasticity Stimulation55%

related🧪Multi-Modal CRISPR Platform for Simultaneous Editing and Mon55%

related🧪Synthetic Biology Rewiring via Orthogonal Receptors55%

related🧪The Mitochondrial-Lysosomal Metabolic Coupling Dysfunction55%

related🧪TFEB-PGC1α Mitochondrial-Lysosomal Decoupling55%

related🧪Ephrin-B2/EphB4 Axis Manipulation55%

related🧪Microbial Inflammasome Priming Prevention55%

related🧪Phase-Separated Organelle Targeting55%

related🧪Nucleolar Stress Response Normalization55%

related🧪Vagal Afferent Microbial Signal Modulation55%

related🧪Cross-Seeding Prevention Strategy55%

related🧪Selective TLR4 Modulation to Prevent Gut-Derived Neuroinflam55%

related🧪Oligodendrocyte Protectin D1 Mimetic for Myelin Resolution55%

related🧪Purinergic P2Y12 Inverse Agonist Therapy55%

related🧪Microbiome-Derived Tryptophan Metabolite Neuroprotection55%

related🧪Endothelial Glycocalyx Regeneration via Syndecan-1 Upregulat55%

related🧪Near-infrared light therapy stimulates COX4-dependent mitoch55%

related🧪FOXO3-Longevity Pathway Epigenetic Reprogramming55%

related🧪Trans-Synaptic Adhesion Molecule Modulation55%

related🧪Sphingomyelin Synthase Activators for Raft Remodeling55%

related🧪RNA Granule Nucleation Site Modulation55%

related🧪Cell-Type Specific TREM2 Upregulation in DAM Microglia55%

related🧪GFAP-Positive Reactive Astrocyte Subtype Delineation55%

related🧪Complement C1QA Spatial Gradient in Cortical Layers55%

related🧪Excitatory Neuron Vulnerability via SLC17A7 Downregulation55%

related🧪APOE Isoform Expression Across Glial Subtypes55%

related🧪ACSL4-Driven Ferroptotic Priming in Disease-Associated Micro55%

related🧪Astrocyte MCT1/MCT4 Ratio Disruption with Metabolic Uncoupli55%

related🧪SIRT3-Mediated Mitochondrial Deacetylation Failure with PINK55%

mentions🔬SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas50%

mentions🧪Senescent Cell Mitochondrial DNA Release50%

mentions🧪Grid Cell-Specific Metabolic Reprogramming via IDH2 Enhancem50%

mentions🧪Astrocytic Lactate Shuttle Enhancement for Grid Cell Bioener50%

mentions🧪Synthetic Biology BBB Endothelial Cell Reprogramming50%

related🔬What are the mechanisms underlying blood-brain barrier trans50%

related🔬What are the mechanisms underlying senolytic therapy for age50%

related🔬The disease-associated microglia (DAM) phenotype involves TR50%

related🔬What are the mechanisms underlying selective vulnerability o50%

related🔬What are the mechanisms underlying blood-brain barrier trans50%

related🔬What are the mechanisms underlying senolytic therapy for age50%

related🔬What are the mechanisms underlying what are the mechanisms b50%

related🔬The disease-associated microglia (DAM) phenotype involves TR50%

related🔬Is disrupted sleep a cause or consequence of neurodegenerati50%

related🔬Comprehensive analysis of immune cell subtypes in neurodegen50%

related🔬What cell types are most vulnerable in Alzheimers Disease ba50%

related🔬What cell types are most vulnerable in Alzheimer's Dise50%

related🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc50%

related🔬SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas50%

related🔬What are the most promising therapeutic strategies for targe50%

related🔬How to break the GBA-alpha-synuclein bidirectional loop for 50%

related🔬Can gut-brain axis modulation prevent or slow Alzheimer'50%

related🔬Astrocytes adopt A1 (neurotoxic) and A2 (neuroprotective) ph50%

mentions🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc40%

mentions🔬How to break the GBA-alpha-synuclein bidirectional loop for 40%

mentions🔬The disease-associated microglia (DAM) phenotype involves TR40%

mentions🔬What are the mechanisms underlying what are the mechanisms b40%

mentions🔬The disease-associated microglia (DAM) phenotype involves TR40%

mentions🔬Is disrupted sleep a cause or consequence of neurodegenerati40%

mentions🔬Comprehensive analysis of immune cell subtypes in neurodegen40%

mentions🔬What are the most promising therapeutic strategies for targe40%

mentions🔬Can gut-brain axis modulation prevent or slow Alzheimer'40%

mentions🔬Astrocytes adopt A1 (neurotoxic) and A2 (neuroprotective) ph40%

mentions🔬What cell types are most vulnerable in Alzheimers Disease ba40%

mentions🔬What cell types are most vulnerable in Alzheimer's Dise40%

related🧪Senescent Cell Mitochondrial DNA Release40%

related🧪Grid Cell-Specific Metabolic Reprogramming via IDH2 Enhancem40%

related🧪Astrocytic Lactate Shuttle Enhancement for Grid Cell Bioener40%

related🧪Synthetic Biology BBB Endothelial Cell Reprogramming40%

related🔬What are the mechanisms underlying selective vulnerability o30%